1. The systolic paradox in hypertrophic cardiomyopathy
- Author
-
Kristina H. Haugaa, Vibeke M. Almaas, Thor Edvardsen, Nina E. Hasselberg, Ida S. Leren, Jørg Saberniak, Knut Erik Berge, Lars A. Dejgaard, and Trine F. Haland
- Subjects
medicine.medical_specialty ,Longitudinal strain ,Heart and Cardiomyopathies ,Cardiac Volume ,Speckle tracking echocardiography ,macromolecular substances ,Systolic function ,030204 cardiovascular system & hematology ,Left ventricular hypertrophy ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,cardiovascular diseases ,echocardiography and heart failure with preserved ejection fraction ,Ejection fraction ,business.industry ,Hypertrophic cardiomyopathy ,medicine.disease ,Healthy individuals ,Cardiology ,cardiovascular system ,Cardiology and Cardiovascular Medicine ,business - Abstract
Objective We explored cardiac volumes and the effects on systolic function in hypertrophic cardiomyopathy (HCM) patients with left ventricular hypertrophy (HCM LVH+) and genotype-positive patients without left ventricular hypertrophy (HCM LVH−). Methods We included 180 HCM LVH+, 100 HCM LVH− patients and 80 healthy individuals. End-Diastolic Volume Index (EDVI), End-Systolic Volume Index (ESVI) and ejection fraction (EF) were assessed by echocardiography. Left ventricular (LV) global longitudinal strain (GLS) was measured by speckle tracking echocardiography. Results EDVI and ESVI were significantly smaller in HCM LVH+ compared with HCM LVH− patients (41±14 mL/m2 vs 49±13 mL/m2 and 16±7 mL/m2 vs 19±6 mL/m2, respectively, both p
- Published
- 2017